http www.abcam.com glutathione-s-transferase-mu-antibody-epr19362-ab108524.html Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression Immunogen corresponding to Recombinant Full Length Protein corresponding to Human GSTM1. Anti-Glutathione S Transferase mu antibody

For cryo-EM analysis, SLC33A1 MAP was solubilized in 2% lauryl maltose neopentyl glycol (Anatrace, NG310), 0.2% cholesteryl hemisuccinate Tris salt (Anatrace, CH210), 50LmM HEPES (pH-adjusted with KOH, pHL7.4), 150LmM KCl supplemented with protease-inhibitor cocktail (1LmM phenylmethylsulfonyl fluoride (PMSF), 2.5LmgLml 1 aprotinin, 2.5LmgLml 1 leupeptin, 1LmgLml 1 pepstatin A) and DNase I

Gut-derived immune activation exacerbates central pathology in stroke and in autoimmune diseases like MS, while there is evidence that dietary interventions and probiotics can also attenuate disease severity and improve functional outcome

Common findings include reduced microbial diversity, depletion of short-chain fatty acid (SCFA)-producing genera, and enrichment of pro-inflammatory taxa

It requires two stages of conversion and the intervention of the enzymes glutamate-cysteine ligase and glutathione synthetase

Asada, 1999)